AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
201.47
+2.83 (1.42%)
At close: Aug 13, 2025, 4:00 PM
201.50
+0.03 (0.01%)
After-hours: Aug 13, 2025, 7:52 PM EDT
AbbVie Stock Forecast
Stock Price Forecast
According to 20 professional analysts, the 12-month price target for AbbVie stock ranges from a low of $190 to a high of $255. The average analyst price target of $216.1 forecasts a 7.26% increase in the stock price over the next year.
Price Target: $216.10 (+7.26%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 7 | 7 | 7 | 5 |
| Buy | 10 | 11 | 11 | 11 | 11 | 11 |
| Hold | 3 | 4 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 23 | 23 | 23 | 23 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $231 | Buy | Initiates | $231 | +14.66% | Aug 12, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $216 → $227 | Strong Buy | Maintains | $216 → $227 | +12.67% | Aug 1, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $250 → $255 | Buy | Maintains | $250 → $255 | +26.57% | Aug 1, 2025 |
| Raymond James | Raymond James | Buy Maintains $227 → $236 | Buy | Maintains | $227 → $236 | +17.14% | Aug 1, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $210 → $205 | Strong Buy → Hold | Downgrades | $210 → $205 | +1.75% | May 14, 2025 |
Financial Forecast
Revenue This Year
61.25B
from 56.33B
Increased by 8.72%
Revenue Next Year
66.23B
from 61.25B
Increased by 8.14%
EPS This Year
12.39
from 2.39
Increased by 418.32%
EPS Next Year
14.29
from 12.39
Increased by 15.33%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 64.3B | 70.7B | 75.8B | ||
| Avg | 61.2B | 66.2B | 71.0B | ||
| Low | 58.2B | 61.0B | 65.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.2% | 15.4% | 14.5% | ||
| Avg | 8.7% | 8.1% | 7.2% | ||
| Low | 3.3% | -0.4% | -0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.34 | 15.83 | 18.01 | ||
| Avg | 12.39 | 14.29 | 15.82 | ||
| Low | 11.56 | 12.68 | 13.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 457.9% | 27.8% | 26.0% | ||
| Avg | 418.3% | 15.3% | 10.8% | ||
| Low | 383.8% | 2.4% | -2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.